TOP TIERMARKET NEWSWIRE
Movers explained · 2026-11-20

Archived explainer. For the current picture see today's SLS page.

Why Is SELLAS LIFE SCIENCES (SLS) Stock Down Today?

By the Top Tier Newswire AI Desk · November 20, 2026 at 12:02 AM ET · reviewed against 12 wire stories

SELLAS LIFE SCIENCES (SLS) is down -17.21% in the latest session. Our newswire has captured 12 stories on SLS across 7 sources in the last 36 hours, with AI sentiment reading bearish (avg 29/100).

Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.

Sellas Life Sciences (SLS) shares fell 17.21% to $14.86 following the pricing of a $150 million underwritten public offering. The sharp decline marks the stock’s worst rout since January, driven by the dilution from the sale of 11.54 million shares at $13 per share.

What Happened

The company priced an underwritten public offering of common stock, generating expected gross proceeds of $150 million. The transaction involves the sale of 11.54 million shares at a price of $13.00 per share. Expected net proceeds are estimated at $140.6 million, which exceeds the company’s September cash balance by $5.9 million. If the underwriters exercise their option to purchase additional shares, the total net proceeds could reach $161.8 million. This capital raise follows recent positive topline results from the company’s pivotal Phase 3 REGAL trial.

What The Data Shows

The stock had risen 77.5% over the last eight sessions, moving from $8.37 to $14.86, before this pullback. On November 19, 2026, the shares printed six fresh 52-week highs and 11 fresh 52-week lows. The company remains unprofitable with a trailing twelve-month EPS of -0.20 and a market capitalization of $3.9 billion. Its beta of 2.70 indicates high volatility relative to the market. The 52-week range spans from $1.39 to $24.89.

Unusual options activity in the last 36 hours included six notable prints, with call premium totaling $3.9 million against zero put premium. The largest single print was $1.4 million. Retail chatter on platforms like r/wallstreetbets and r/pennystocks reflects recent gains, with users expressing gratitude for the stock’s performance. However, social media volume remains low, with zero posts on X in the last 24 hours and three Reddit mentions in the past seven days.

What To Watch

Investors will monitor the completion of the offering, including whether the underwriters exercise their option to purchase additional shares. The closing date for the offering is set for November 20. Attention will also remain on the company’s ongoing clinical developments and any further regulatory updates following the Phase 3 REGAL trial results.

AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.

SLS by the numbers

Last: $14.86Session: -17.21%7 sessions: +77.54%Coverage: 12 stories / 7 sourcesAI sentiment: 29/100 (bearish)Mkt cap: $3.9B52w: $1.39 to $24.89
SLS · today's session (5-min) · -8.55% vs prior close · updated 12:44 PM ET
$13.30$14.32$15.34prev close $14.86$13.597:00 AM8:25 AM9:50 AM11:15 AM12:40 PM7:00 AM · $14.657:05 AM · $14.727:10 AM · $14.767:15 AM · $14.777:20 AM · $14.757:25 AM · $14.707:30 AM · $14.727:35 AM · $14.807:40 AM · $14.757:45 AM · $14.667:50 AM · $14.727:55 AM · $14.708:00 AM · $14.688:05 AM · $14.718:10 AM · $14.748:15 AM · $14.698:20 AM · $14.698:25 AM · $14.688:30 AM · $14.668:35 AM · $14.668:40 AM · $14.708:45 AM · $14.748:50 AM · $14.828:55 AM · $14.989:00 AM · $15.009:05 AM · $15.239:10 AM · $15.199:15 AM · $15.129:20 AM · $15.089:25 AM · $15.039:30 AM · $14.929:35 AM · $14.879:40 AM · $14.759:45 AM · $14.829:50 AM · $14.609:55 AM · $14.6810:00 AM · $14.3810:05 AM · $14.2110:10 AM · $14.0510:15 AM · $14.0810:20 AM · $13.8210:25 AM · $13.7910:30 AM · $13.8210:35 AM · $13.8110:40 AM · $14.0210:45 AM · $14.0710:50 AM · $14.0410:55 AM · $13.7911:00 AM · $13.8511:05 AM · $13.8911:10 AM · $13.9611:15 AM · $13.8811:20 AM · $13.8811:25 AM · $13.9011:30 AM · $13.7911:35 AM · $13.7911:40 AM · $13.8511:45 AM · $13.7611:50 AM · $13.6311:55 AM · $13.6312:00 PM · $13.4612:05 PM · $13.4112:10 PM · $13.4912:15 PM · $13.4512:20 PM · $13.5712:25 PM · $13.5912:30 PM · $13.6612:35 PM · $13.5712:40 PM · $13.59
AI sentiment, last 36h · averaged over 12 stories · 29/100 bearish
AI sentiment 29/100 (bearish)0 · bearish50bullish · 100

The headlines behind the move

Story flow · 8 stories on the wire, last 36h · hover or tap a dot for the headline
36h ago24h ago12h agopublishThe Fly · sentiment 28 · Sellas Life Sciences 11.5M share Secondary priced at $13.00The Fly · 28Sellas Life Sciences 11.5M share Secondary priced at $13.00Seeking Alpha · sentiment 22 · SELLAS Life Sciences prices $150M public offering of common stockSeeking Alpha · 22SELLAS Life Sciences prices $150M public offering of common stockGuruFocus · sentiment 24 · SELLAS Life Sciences Group (SLS) Prices $150M Public Offering Ahead of November 20 ClosingGuruFocus · 24SELLAS Life Sciences Group (SLS) Prices $150M Public Offering Ahead of November 20 ClosingStocktwits News · sentiment 62 · Stock Futures Climb Ahead Of Anthropic's Nasdaq Debut — NVDA, BABA, TTWO, SLS Stocks In FocusStocktwits News · 62Stock Futures Climb Ahead Of Anthropic's Nasdaq Debut — NVDA, BABA, TTWO, SLS Stocks In F…MarketWatch · sentiment 22 · Sellas Life Sciences Shares Sink After Pricing Public OfferingMarketWatch · 22Sellas Life Sciences Shares Sink After Pricing Public OfferingThe Fly · sentiment 31 · Sellas Life Sciences falls -13.8%The Fly · 31Sellas Life Sciences falls -13.8%The Fly · sentiment 22 · Sellas Life Sciences falls -18.3%The Fly · 22Sellas Life Sciences falls -18.3%Stocktwits News · sentiment 28 · SLS Stock Suffers Worst Rout Since January After $150M Share Sale — But Fresh Filing Has Retail Bulls Saying Sellas Has More Buyout LeverageStocktwits News · 28SLS Stock Suffers Worst Rout Since January After $150M Share Sale — But Fresh Filing Has …
13h agoStocktwits NewsBEARISH 28General

SLS Stock Suffers Worst Rout Since January After $150M Share Sale — But Fresh Filing Has Retail Bulls Saying Sellas Has More Buyout Leverage

Expected net proceeds of $140.6 million exceed September cash by $5.9 million and could reach $161.8 million if underwriters exercise their option.

1d agoThe FlyBEARISH 22General

Sellas Life Sciences falls -18.3%

1d agoThe FlyBEARISH 31General

Sellas Life Sciences falls -13.8%

1d agoMarketWatchBEARISH 22General

Sellas Life Sciences Shares Sink After Pricing Public Offering

1d agoStocktwits NewsBULLISH 62General

Stock Futures Climb Ahead Of Anthropic's Nasdaq Debut — NVDA, BABA, TTWO, SLS Stocks In Focus

Oil futures edged higher as traders weighed supply glut concerns against rising tensions in the Strait of Hormuz.

1d agoGuruFocusBEARISH 24General

SELLAS Life Sciences Group (SLS) Prices $150M Public Offering Ahead of November 20 Closing

1d agoSeeking AlphaBEARISH 22General

SELLAS Life Sciences prices $150M public offering of common stock

SELLAS Life Sciences Group (SLS) priced an underwritten public offering of 11.54M shares of common stock at $13 per share, generating expected gross proceeds of $150M

1d agoThe FlyBEARISH 28General

Sellas Life Sciences 11.5M share Secondary priced at $13.00

Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →

More on SLS: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.

Earlier SLS move explainers: 2026-11-20 · 2026-11-19 · 2026-11-18 · 2026-11-17 · 2026-11-13 · 2026-10-28 · 2026-10-20 · 2026-10-19 · 2026-08-31 · 2026-08-28 · 2026-08-27 · 2026-08-25 · 2026-08-24 · 2026-08-21 · 2026-08-17